gms | German Medical Science

Table

Table 1: Comparison between groups of patients with node-positive NSCLC: clinical data. Group I, N2-disease in the AP-region; group II, N2-disease at any other level; group III, N2-disease at mediastinoscopy with complete response to induction treatment; group IV, N2-disease at mediastinoscopy with partial or no response to induction treatment; group V, N1-disease in the hilar or interlobar region.